320 likes | 462 Vues
E N D
1. Facing the Care ChallengePracticeA pathway approach to implementing NICE guidanceA nurse led model Susan Oliver MSc FRCN
Nurse Consultant Rheumatology
Independent
2. Stepping into new territorya nurse led inflammatory arthritis model
3. Overview Example of good practice - rheumatology service development
Commissioned service in Oldham
Collaboration between specialist and community services
Transfer of patients to a community based model
Patient experience and needs
Framework, guidelines and workforce
4. Rheumatology Discuss the Rheumatoid Arthritis Example (RA)
Rheumatological conditions e.g.
Inflammatory forms of arthritis, systemic lupus, scleroderma
Inflammatory joint diseases (3%)
Rheumatoid Arthritis, Psoriatic Arthritis
Expensive treatments, quality of life impact, co-morbidities
Need to manage disease control
6. Nursing modelTeam approach
7. Rheumatology Nursing Clinical Nurse Specialists
Studies have demonstrated safety and efficacy equivalent to a junior doctor with ? patient knowledge1
Manage triage and early arthritis clinics2
Cost effective & valued by patients in provision of telephone advice line support 3, 4
Drug monitoring and well being 5
28% are nurse prescribers6
8. Change the way we manage capacity The essence of nursing role in rheumatology but...drivers must
Understand the demand
Measure it
Plan capacity to account for variation in demand
Plan for no waiting list or queue = no delay for nursing care/team approach
Reduce the number of steps in the process
remove non-value adding activities
Reduce the variation in capacity
Reduce the number of queues at each step
Match different team members pathway input
Improve bottleneck productivity = throughput
9. Rationale for evidence based carePathways More...real change in the pipeline1
Commissioners/Consortia lack of knowledge/time/interest
Regional variances in pathways of care
Need to optimise efficiency and highlight quality2
Matching capacity with demand
Structured and rigorous focus on;
Activity (N/FU ratio)
Costs and outcomes
Quality indicators and PROMs
Use of Evidence based care/guidelines
10. Why pathways - patient Transparency of pathway
Ability to plan and consider future issues
Aids documentation and recall of their patient journey
Key points in pathway linked to assessment and outcomes
Quality of Life an important and valued indicator1
11. Why pathways – clinical Greater use of teams expertise
Potential to reduce variances in care
Document clearly exceptions to routine path
Identification of true versus perceived bottlenecks and long waits
Less ‘faces’ but more effective interactions
Bridges gaps between provision
Primary/secondary
NHS/Voluntary sector
12. Why pathways - financial Provider can predict more clearly activity and resources required
All team members providing care are incorporated & costed
Implications regarding cheapest competent practitioner
Costs can be more accurately predicted/plotted against patient flows
Commissioners can identify
Activity + Costs + Outcomes
Variances can help future contracting/financial changes
Managing capacity and demand
13. Healthcare delivery 2010and on.....
14. The future in healthcare delivery Deliver improved services with same amount (or reduced levels) of income
More for less + demonstrate strong evidence of quality and value of steps in service delivered
Identify the patient experience and outcomes
15. Optimising patient careTransparencyEquity of accessThe FoundationsPatient Experience
16. The Healthcare practitioner’s perspective
17. Patient Stories v standards and guidelines
18. First stepsReferral pathway
19. Putting evidence into practice
20. The Nursing Model Biopsychosocial model of care
Optimal management achieved with a holistic and patient centred approach1
Agreed goals
Negotiated treatment plans2
Informed decision making2
Self management & patient preferences2
Transparent framework of support
21. Pennine MSK model for RA Based upon NICE RA management guidelines (2009)
Diagnosis by Consultant Rheumatologist
Referral to nurse led clinics
Intensive management 6 weekly assessment + telephone consultation + rapid access service
Management based on disease control
Red Flags to guide referrals back to medics
Protocol driven treatment plan
Data collection using the EMIS system
Patient held record
Disease control
Reduce follow up care when stabilised to annual review with access to telephone review+ rapid access service
Review by MDT according to need.
22. Framework Patient pathway
All steps in pathway outlined
Each drug outlined with risks and benefits + monitoring
Exceptions and red flags etc – referred back to physician
Patient Group Directions (PGD) and policies
Symptom and disease control
All clinicians actively involved with pathway
A staged and integrated approach to transfer of patients from specialist to community services
23. NICE RA management principlesImplementation Required re-design of services with investment
Patient required early and prompt review until disease control
Heavy front loaded activity required service re-design
Frameworks for nursing practice
Development of nursing competencies
Plan for enhancing nurse specialist expertise
Independent nurse prescribers, joint injection
Policies and patient group directions
Structured patient pathway essential
Capacity and demand
Competencies at each stage of pathway
Clarity re patient on or off pathway and when to seek medical advice
24. The Nursing issues – started with Overall accountability Nurse Consultant (Partner)
One PT Nurse Consultant
(Independent – contracted service)
1 Part Time(PT) Nurse Specialist in rheumatology (band 8)
2 PT nurses working in service who required additional training (band 6)
Osteoporosis and practice nurse /community nurse expertise
2-3 Healthcare workers – chiefly deployed in orthopaedic, triage and pain services
Good administrative support and management
25. Patient clinical assessment cycle
26. Innovation example Patient benefits & Cost effective Background: Specialist services cost - day care activity patients attending for intramuscular methotrexate (once a week) 30 patients tariff (£655 pp)day case tariff.
Innovation:
Community education day all patient invited
Education on conversion from IM to Subcutaneous methotrexate.
Group sessions of 6 with nurse to teach SC administration
Presentations by team and supplier of new treatment option (delivered to patients home)
PCT made significant cost savings/patients care improved
27. On-going transfers Status > 800 <2000 patients transferred from specialist services to community services
Chiefly managed by nurses following diagnosis
Treating to target according to NICE principles
Tracking on or off pathway
Patient involvement
Customer Excellence Award (2009)
28. Demonstrating the value of new models Historical challenges in demonstrating the unique value of the nurse specialist in improving patient care (Oliver and Leary 2010).
Computer system – templates and data systems
Proposed new electronic system being considered incompatible with previous system
Continuous education training/updates to team to maintain pathway approach
Breaking old habits sustaining new ones
New policy changes/resource/funding
Training of nursing team
New substantive part time senior rheumatology lead nurse (PT)
Undertaking joint injection course
1 Nurse undertaking Prescribing course & 1 on waiting list for NPC
1 nurse attending rheumatology masters & 1 BSC course on chronic disease nursing
29. Opportunities Nursing workforce
Various expertise provided additional patient benefits
Competencies in;
cardiovascular disease and assessment
osteoporosis management
Orthopaedic referral and assessment
Newly appointed nurse – linked to academic unit to support on-going training and development
Enhanced participation and standards of care with all multi-disciplinary team
Patient input vital to service development
30. Issues Evidence based practice balanced with health policy drivers/costs
Disease specific evidence versus generic evidence
Still limited research in specific disease areas undertaking new models of care
Targets and quality indicators
Data capture of benefits traditionally focus on target driven areas
80% of referrals seen with 3 weeks.
Patient Satisfaction Surveys regularly undertaken
(see website) http://www.pmskp.org/index.html
31. Evaluation Frequent reviews of service and team working to:
Review deviance from pathways and planning needs
Develop robust quality indicators
Include tools for ethnic and minority needs
Improve patient involvement
Consider patient population
Review governance and competencies
Demonstrate cost effectiveness
New frameworks/commissioners
Data collection should show benefits re steps of pathway
quality indicators, patient experience and cost effectiveness (QUIPPs).
Consider the impact of high quality administrative support to nurse activity
32. ConclusionNurse Led Models Evidence in the provision of specialist disease specific nursing interventions remain scanty
Nurse Prescribers benefit patient journeys in managing risk and advising GPs
Protocols/policy/PGDs labour intensive but essential
Patient outcomes and cost effectiveness are not mutually exclusive.
33. Discussions